Earnings Outlook For Enfusion
Portfolio Pulse from Benzinga Insights
Enfusion (NYSE:ENFN) is scheduled to release its quarterly earnings report on March 12, 2024, with an estimated EPS of $0.05. Historical performance shows mixed results with the last quarter missing estimates, leading to a 3.72% increase in share price the following day. Over the past year, ENFN shares have declined by 25.29%, indicating a bearish outlook among long-term shareholders.
March 11, 2024 | 3:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Enfusion is expected to report an EPS of $0.05 for the upcoming quarter. Historical earnings performance has been mixed, with the last quarter missing estimates but still resulting in a share price increase. Shares have declined 25.29% over the past year.
Given Enfusion's mixed historical earnings performance and the significant decline in share price over the past year, the upcoming earnings report could maintain the current stock price or induce minor fluctuations. However, the exact impact will heavily depend on whether the company meets or exceeds the EPS estimate and the forward guidance provided.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100